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ABSTRACT 
Background: Obesity is a known risk factor for cardiovascular morbidity and 
mortality, as well as for atrial fibrillation and heart failure. While overweight 
and obesity have become increasingly more common in Sweden and 
worldwide during the past decades, there have also been an increase of some 
cardiovascular diseases (CVD) among men and women younger than 45 
years old in Sweden. Significant weight loss has several beneficial effects on 
these conditions. Bariatric surgery has shown to induce great weight loss and 
to improve cardiac function. 
Aims and methods: The aim of this thesis was to investigate trends in mean 
body mass index (BMI), overweight and obesity in young women during past 
decades. Thereto, we sought to estimate the impact of body size, body weight 
and obesity on the risk of early CVD and mortality in young women and in 
obese patients with and without surgical treatment for obesity, and compare 
that risk with the Swedish total population. All studies included in this thesis 
are population-based trend- and cohort-studies, and are based on data from 
Swedish national registries. In Study I–III, the study populations were 
derived from the Medical Birth Register and included all women in Sweden 
who gave birth between 1982 and 2014. In Study IV–V, the Patient Register 
was used to create cohorts including all individuals diagnosed with obesity, 
with and without bariatric surgery, between 2000 and 2011 and between 2001 
and 2013. Logistic regression models were used to analyze the relationship 
between BMI and socioeconomic status. To analyze the relationship between 
BMI, obesity, obesity surgery and morbidity and mortality in CVD, Kaplan-
Meier curves, Cox regression, Poisson regression, and logistic regression 
were applied. 
 
Results: The incidence of obesity has significantly increased among young 
women since 1982. This increase was observed in all levels of education and 
in all counties in Sweden. An increased body weight and body size early in 
life is strongly associated with an increased risk of early heart failure and 
atrial fibrillation among women. There was a linear relationship between 
BMI measured early in life and an increasing risk of developing early heart 
failure, starting already at BMI 22.5–25, among women. The risk of heart 
failure and acute myocardial infarction (AMI) was markedly reduced among 
patients with a diagnosis of obesity who had undergone obesity surgery 
compared with patients with a diagnosis of obesity who had not undergone 
such surgery. Within 3 years of follow-up, they also had a reduced risk of 
cardiovascular-related and all-cause mortality, but not during 3–10 years of 
follow-up. Obesity surgery did not seem to affect the risk of developing 
ischemic stroke to the same extent. Compared with the total population, 
patients with a diagnosis of obesity who have undergone obesity surgery 
have the same risk of AMI during 10 years of follow-up. They also had a 
similar risk of developing ischemic stroke during the first three years, after 
which the risk increased again. 
Conclusions: Given the strong associations identified between an elevated 
body size and BMI early in life and increased risk of atrial fibrillation and 
heart failure, along with increased risk of heart failure, AMI, and premature 
death among patients with obesity, the illuminated increase in obesity among 
young first time-mothers will most likely cause a rice in serious health 
problems in Sweden the following decades. 
Keywords: epidemiology, body mass index, obesity, bariatric surgery, 
gastric bypass, cardiovascular disease, mortality 
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SAMMANFATTNING PÅ SVENSKA 
Bakgrund: Fetma är en känd riskfaktor för kardiovaskulär sjuklighet och 
dödlighet, liksom för förmaksflimmer och hjärtsvikt. Samtidigt som övervikt 
och fetma har blivit allt vanligare i Sverige och världen över under de senaste 
decennierna, har det också skett en ökning av förekomsten av vissa hjärt-
kärlsjukdomar bland män och kvinnor yngre än 45 år i Sverige. En betydande 
viktminskning har ett flertal fördelaktiga effekter på dessa tillstånd. 
Fetmakirurgi har visats inducera en signifikant viktminskning och förbättrad 
hjärtfunktion. 
Metoder: Syftet med denna avhandling var att undersöka trender i 
kroppsmasse index (body mass index [BMI]), övervikt och fetma under de 
senaste decennierna. Därtill var syftet att estimera påverkan av kroppsyta, 
kroppsvikt och fetma på förtida sjuklighet och dödlighet i hjärt-
kärlsjukdomar bland unga kvinnor och bland patienter med fetma, med och 
utan fetmakirurgi, samt att jämföra den risken med den svenska 
befolkningens. Studierna som inkluderas i avhandlingen är populations-
baserade trend- och kohortstudier, och bygger på data ifrån svenska 
nationella register. I Studie I–III skapades studiepopulationerna utifrån 
medicinska födelseregistret och inkluderade alla kvinnor i Sverige som fött 
barn mellan 1982 och 2014. I Studie IV–V användes patientregistret för att 
skapa kohorter med alla individer som fått en fetmadiagnos med och utan 
fetmakirurgi, mellan åren 2000–2011 samt mellan åren 2001–2013. För att 
analysera sambandet mellan BMI och socioekonomisk status användes 
logistiska regressionsmodeller. För att analysera sambandet mellan BMI, 
fetma, fetmakirurgi och insjuknande och dödlighet i hjärt-kärlsjukdomar 
tillämpades Kaplan-Meier kurvor, Coxregression, Poisson-regression, samt 
logistisk-regression. 
Resultat: Förekomsten av fetma har ökat avsevärt bland unga kvinnor sedan 
1982. Denna ökning observerades i alla utbildningsnivåer och i alla län i 
Sverige. En ökad kroppsvikt och kroppsyta mätt tidigt i livet är starkt 
förknippat med en ökad risk för tidig hjärtsvikt och flimmer bland kvinnor. 
Det fanns ett linjärt samband mellan BMI mätt tidigt i livet och en ökande 
risk för att utveckla tidig hjärtsvikt bland kvinnor. Den förhöjda risken 
började redan vid BMI 22.5–25. Risken för hjärtsvikt och hjärtinfarkt var 
kraftigt reducerad för patienter med en fetmadiagnos som hade genomgått 
fetmakirurgi jämfört med patienter med en fetmadiagnos som inte genomgått 
sådan kirurgi. Inom tre års uppföljning så hade de även minskad risk för 
kardiovaskulärrelaterad och all typ av dödlighet, men inte under 3–10 års 
uppföljning. Fetmakirurgi verkade inte påverka risken att insjukna i 
ischemisk stroke i lika stor utsträckning. Jämfört med totalbefolkningen så 
har patienter med en fetmadiagnos som har genomgått fetmakirurgi samma 
risk att drabbas av hjärtinfarkt under 10 års uppföljning. På kort sikt hade de 
även liknande risk att insjukna i ischemisk stroke, därefter ökade risken 
återigen. 
Slutsatser: Givet den starka association som identifierats mellan ett högt BMI 
och kroppsyta tidigt i livet och senare ökad risk för hjärtsvikt och flimmer 
samt mellan fetma och tidigt insjuknande i hjärtsvikt, hjärtinfarkt och förtida 
död, så kommer den ökning av fetma och grav fetma som identifierats bland 
unga kvinnor sedan 1982 och framåt på sikt sannolikt medföra en ökning i 
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OVERWEIGHT AND OBESITY 
PREVALENCE 
The prevalence of overweight and obesity has nearly tripled in Sweden and 
worldwide during the past 50 years,1 and is now a major global public health 
problem. The global prevalence of overweight in 2016 was at 39% and that 
of obesity at 13%.2 A particular matter of concern is that 18% of all children 
and adolescents aged 5–19 were overweight or obese in 2016. This sharp 
increase in a matter of just a few decades has caused the World Health 
Organization (WHO) to declare a global obesity epidemic.2 In Sweden, more 
than half of the adult population were overweight and almost 20% were 
obese in 2013.3 In particular, the prevalence of severe obesity, defined as a 
body mass index (BMI) of ≥35 kg/m2 has more than doubled in Sweden and 
worldwide during the last few decades. In young Swedish men (mean age 18 
years), the prevalence of obesity (BMI>30 kg/m2), increased from around 1% 
during 1969–1974 to 3.4% during 1996–2005, where the highest prevalence 
difference between periods was found in severe  and morbid obesity (BMI> 
40kg/m2). The increase was substantially higher for those young men whose 
parents had the lowest educational level.4 Similarly, among young Swedish 
women (mean age 28 years) with weight recorded at their first antenatal visit, 
obesity increased from 4.5% to 10.2% between 1992 and 2010.5 However, 
data on temporal trends in prevalence of moderate and severe obesity in 
young women are limited.  
CLASSIFICATIONS AND DEFINITIONS  
The WHO’s definition of overweight and obesity is “abnormal and excessive 
fat accumulation that may impair health”.2 There are several anthro-
pometrical measures which can be used to assess overweight and obesity, 
such as BMI, waist circumference, sagittal abdominal diameter and body 
surface area, which all have their advantages and disadvantages. BMI is the 
most commonly used proxy for assessing overweight and obesity across 
populations.2 BMI is calculated as the weight in kg divided by the height in 
m2.6 The most recent classifications of weight status, defined by WHO, along 
with definitions used in this thesis can be found in Table 1. Because previous 
research has indicated that the risk of several CVD starts already at what 
WHO defines as normal weight,7, 8 further subdivision of this category may 
be appropriate in order to capture potential differences in risk within 
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be appropriate in order to capture potential differences in risk within 
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Table 1. Classification of weight status according to the WHO with further 
subdivision of the normal weight category as used in this thesis. 
BMI WHO classification Classifications used in thesis 
< 18.5 Underweight Underweight 
18.5 to <20.0 Normal weight Low normal weight 
20.0 to <22.5 Normal weight Normal weight 
22.5 to <25.0 Normal weight High normal weight 
25.0 to <30.0 Pre-obesity  Overweight 
30.0 to <35.0 Obesity class I Obesity 
35.0 to <40.0 Obesity class II Severe obesity 
> 40.0 Obesity class III Morbid obesity 
Abbreviations: BMI= body mass index, WHO= World Health Organization 
 
CAUSES AND CONSEQUENCES OF OVERWEIGHT 
AND OBESITY 
CAUSES 
The basic physiological cause of the accumulation of overweight is an 
imbalance between calory intake and expenditure. Therefore, both diet and 
physical activity are of importance for maintaining energy balance and a 
healthy weight.9 There is a large body of evidence showing that a good 
dietary pattern is of great importance in order to maintain a good health and a 
healthy weight.10 A healthy eating pattern, associated with lower prevalence 
of cardiovascular risk factors, is characterized by a high intake of high-fibre 
and low-fat foods, and a low intake of foods containing high levels of fat or 
sugar.11 To the contrary, over the past decades, there has been a substantial 
increase in the intake of ultra-processed, energy-dense food, containing high 
levels of fat and sugar and with a low nutritional value, in Sweden and 
worldwide.12, 13 Simultaneously, the overall physical activity level has 
decreased and been replaced by a more sedentary lifestyle,2 where an 
estimated one third of the population in the Nordic countries was physically 
inactive in 2014.14  
The causes of this shift towards more unhealthy behaviours, associated with 
increased levels of overweight and obesity worldwide, are multifactorial.15 
The relationship between factors and causes of obesity have been well 
illustrated in the Obesity System Influence Diagram.16 The map shows how 
overweight and obesity are caused by genetic, behavioural, socioeconomic 
and environmental factors. In the diagram the causes of obesity are divided 
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into clusters of factors such as biology, early life growth patterns, living 
environment and infrastructure, economic drivers of food production and 
consumption, along with food intake and physical activity behaviours. All 
these factors together have created new “obesogenic” environments, 
promoting unhealthy lifestyles, and are making it harder for individuals to 
attain healthy lifestyles. This is especially true for younger people who are 
growing up in these environments. For example, these factors have promoted 
and caused overconsumption of unhealthy foods, poor dietary habits, low 
levels of physical activity, and with this, difficulties in maintaining a healthy 
weight.17 What has especially affected dietary habits is the availability of 
low-cost ultra-processed foods along with major investments in marketing of 
such products.17 Furthermore, increasing levels of physical inactivity are the 
result of more automated work, increasingly sedentary occupations, higher 
levels of screen time, and, with motorized transport, less engaging in 
physically active commuting.14, 18 
THE ROLE OF SOCIOECONOMIC STATUS 
There is a large body of evidence showing an association between socio-
economic status and weight, where a lower socioeconomic status is 
associated with an increased risk of overweight and obesity. Contextual 
factors which cause an uneven distribution of overweight and obesity include 
factors such as cultural identity, gender, economy, physical and social 
environment, social networks, and socioeconomic status.19 In addition, 
obesogenic environments are often related to poor socioeconomic conditions, 
hence, younger people with low socioeconomic status who are growing up in 
these environments are set on a path leading to increased risk of obesity 
already in young adulthood.20 Widening social inequalities have been 
observed during the last decades in both men, women and youths 
worldwide.20-22 In Sweden, individuals living in areas with low socio-
economic status have shown to have lower levels of physical activity and 
higher prevalence of CVD risk factors.23 This inequality of health in the 
population is a challenge for the health care system. 
CONSEQUENCES 
Overweight and obesity are major causes of premature disability, morbidity 
and mortality.24, 25 Excess weight is the cause of multiple adverse health 
effects, such as CVD, diabetes, musculoskeletal disorders, system 
inflammation and some cancers.25-27 Overweight and obesity are also 
associated with poor quality of life, learning disabilities and poor school 
performance among children.28 The onset of overweight and obesity early in 
life is associated with an increased risk of remaining overweight and obese 
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during adulthood, inducing a lifelong weight struggle.29 The tracking of 
obesity into adulthood causes more severe medical complications than if 
obesity develops during adulthood.30 Because of this, obesity has a major 
impact on public health, imposing a significant financial burden on national 
health services. In particular, this is true for morbid obesity.31 
OBESITY AND CARDIOVASCULAR DISEASE 
CORONARY HEART DISEASE 
In Sweden, the overall mortality from coronary heart disease (CHD) 
decreased by approximately two-thirds for men and women aged 35–84 years 
between 1987 and 2009.32 Despite this overall downward trend in Sweden 
and worldwide,24, 32 CVD, mainly CHD and stroke, are the leading cause of 
death worldwide.24, 33 Approximately 70% of all deaths globally among 
individuals with obesity is attributed to CVD.26 However, premature deaths 
from CVD are to a large extent preventable. 
There are several pathways between obesity and excess weight on the risk of 
CHD. In short, the predominant underlying cause of CHD is atherosclerosis, 
a chronic inflammatory artery disease that leads to the appearance of plaque 
in the coronary vessel wall.34 The prevalence of plaque increases with age, 
appearing earlier  in men than in women, and is largely caused by metabolic 
risk factors which, in turn, to a major extent are related to lifestyle, leading to 
modifiable risk factors such as hypertension, dyslipidemia, and diabetes. 
INTERHEART, a large retrospective case-control study investigating causes 
of acute myocardial infarction (AMI) in 52 countries found that 90% of the 
cases could be attributed to 9 modifiable risk factors,35 confirming that good 
dietary patterns, adequate physical activity and a healthy weight, in addition 
to abstaining from smoking, are the key factors in preventing AMI.10, 36, 37  
The accumulation of excess weight in itself causes metabolic dysfunction, 
which increases blood pressure along with increased glucose and lipid levels, 
which are mediators in the pathway towards developing diabetes, atrial 
fibrillation, heart failure, ischemic stroke and CHD.26, 38, 39 In addition, 
significant weight loss has several beneficial effects on cardiovascular 
morbidity and mortality caused by obesity.40, 41 The increase in overweight 
and obesity is thought to partly explain a levelling-off, or even increase, of 




Heart failure is a serious clinical condition, with 5-year mortality rates similar 
to that of many cancers, despite improvements in treatment.46 The prevalence 
of heart failure in the adult population in high-income countries is estimated 
at approximately 1–2%, and the lifetime risk among men and women aged 55 
years at approximately 1 in 3.47 Heart failure is a leading cause of mortality 
among men and women aged 65 years and older,48 and the risk of heart 
failure increases steeply with age.49 In recent years, heart failure has become 
increasingly common among younger persons, aged <45 years, in Sweden42 
and Denmark.50 Obesity and an elevated BMI are strong well-known risk 
factors for heart failure.7, 51, 52 Hence, the increasing levels of overweight and 
obesity in Sweden5, 53 and worldwide54 could potentially explain rising rates 
of heart failure among younger persons. A previous study of young men 
(aged 18–25 years old) found a steep increase in risk of early heart failure 
with increasing BMI, with an up to 10-fold increase in risk among those with 
BMI>35 compared with BMI 18.5–20 kg/m2.7 In this thesis we sought to 
investigate whether a similar association between elevated BMI and heart 
failure  existed also in young women. 
Heart failure is a condition defined by typical symptoms of breathlessness, 
ankle swelling and fatigue, along with clinical signs caused by a structural 
and/or functional cardiac abnormality, which in turn causes reduced cardiac 
function.47 Heart failure is an important component in CVD and represents an 
advanced stage of a variety of cardiovascular disorders without a clear single 
classification of causes.47 The most prominent causes of heart failure in 
Sweden and other high-income countries are hypertension and CHD.51 Heart 
failure can also be a result of acquired or congenital heart disease, 
arrhythmias or cardiomyopathies. In addition, there is a close link between 
atrial fibrillation and heart failure, where atrial fibrillation is both a risk factor 
and an adverse cardiovascular outcome associated with heart failure.55, 56 
ATRIAL FIBRILLATION 
Atrial fibrillation is the most common sustained cardiac arrhythmia, with 
around 43.6 million cases worldwide in 2016.57 The lifetime risk of 
developing atrial fibrillation is 1 in 3 at an index age of 55 years57 and the 
risk increases steeply with age and is higher for men.58 Atrial fibrillation is 
one of the major causes of stroke, cardiovascular mortality and heart 
failure.55, 56 Although atrial fibrillation is more common in men, it is 
associated with a greater risk for stroke and cardiovascular death among 
women, compared to men.55 
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There are numerus genetic and modifiable risk factors for incident atrial 
fibrillation, which in turn also is associated with aging and male sex, 
including hypertension,59 valvular disease, diabetes, renal failure, chronic 
artery disease,60, 61 physical activity, alcohol intake, smoking and obesity.57 
Obesity and elevated BMI have increasingly been recognised as major risk 
factors for atrial fibrillation.62-64 The increased risk associated with obesity 
seems to be mediated trough left atrial dilation,65 increased left ventricular 
mass and diastolic dysfunction.56, 66 Together with BMI, both an elevated 
waist circumference and sagittal abdominal diameter, and weight gain over 
the life course, have independently been associated with atrial fibrillation in 
middle-aged populations.62, 63, 67 Some studies have found a strong correlation 
between stature, measured by both height and body surface area (BSA), and 
the risk of atrial fibrillation, in a male population67 and in a large patient 
population with impaired left ventricular function.68 BSA has shown to be the 
best predictor of atrial fibrillation in healthy older populations,69 while an 
increased BMI and BSA measured in young men (aged 18 years old) showed 
to be associated with an increased risk of atrial fibrillation later in life.70 
However, this relationship has not been investigated in women. As the height 
across the world’s population on average has increased by 5 to 10 cm since 
1900,71 along with increasing mean BMI,54 it is of interest to further explore 
the relationship between weight and height to that of incidence of atrial 
fibrillation. 
TREATMENT OF OBESITY 
Overweight and obesity are to a large extent preventable through a supportive 
environment that promotes healthy behaviors and makes it easier for 
individuals to choose healthy foods, and to attain adequate levels of physical 
activity in order to maintain a healthy body weight.72 However, to date there 
are few successful treatments for obesity resulting in sustained weight loss. 
Currently, there are three main types of treatments available for obesity. 
These are life style interventions, pharmacotherapy, and bariatric surgery.73 
Although lifestyle interventions and pharmacotherapy are important and 
meaningful treatments, bariatric surgery has been shown to be the most 
effective treatment with regards to sustained weight loss for individuals with 
severe and morbid obesity.73, 74 
BARIATRIC SURGERY 
Bariatric surgery is a collective name for restrictive and/or malabsorptive 
surgeries with the purpose of physically restricting the size of the stomach, 
slowing down digestion, by removing or by-passing parts of the digestive 
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tract, reducing absorption of calories.75 In Sweden, the treatment is usually 
initiated with a very low energy diet for a period of weeks, depending on the 
patient’s starting weight. Post-surgery the patients are given nutritional 
recommendations and lifestyle guidance, and are followed up within the 
public healthcare at 6 weeks, and at 6-, 12-, and 24-months post-surgery.76 
Those eligible for surgery are patients with BMI >40, or BMI >35 with 
serious obesity related complications, such as diabetes, hypertension, and 
sleep apnea.77 Contraindications to surgery are drug and alcohol abuse, 
psychiatric disorders, cancer within the last five years, and general poor 
mental or physical health.78 
In Sweden and worldwide, the number of bariatric surgery procedures have 
increased along with the increase in prevalence of obesity and morbid 
obesity.79 From 2000 and onwards, bariatric surgery became increasingly 
popular as a treatment for severe and morbid obesity in Sweden,80 and 
between 2000 and 2014, the most commonly performed bariatric surgery was 
the Roux-en-Y gastric bypass (RYGB).80 Bariatric surgery in general, and 
RYGB in particular, have shown to improve prognosis for patients with 
morbid obesity through a significant initial weight loss. Reports from the 
Scandinavian Obesity Surgery Registry have shown that patients who 
undergo bariatric surgery on average have BMI >45 at time of the surgery. 
During the year after surgery the BMI usually stabilizes around 32, after 
which the patients remain weight stable for about 5 years, after which there is 
usually some recurrent weight gain.81 The Swedish Obese Subjects study 
(SOS) is the largest and most longstanding of the non-randomized trials, 
starting in 1987, comparing 2,010 patients undergoing obesity surgery with 
2,037 matched usual care obese controls, demonstrating significant and 
largely persistent weight loss as well as remission of type 2 diabetes, lower 
rates of AMI, onset of new diabetes and mortality from all causes.82 
However, only about 30% of the participants underwent RYGB, and only 
patients aged 37 and older were included in the study.  
RYGB is associated with improved cardiac function,83, 84 and improvements 
in blood pressure, blood lipid levels, and dysglycemia.84, 85 The surgery is 
also associated with improvement or complete resolution of obesity-related 
cardiovascular risk factors in morbidly obese patients.82, 86 Still, some 
relapses of obesity related comorbidity have been observed along with 
accumulating weight gain during 5 years post-surgery.85 Due to limited study 
sizes, there are few studies that have been able to study the risk of fatal and 
non-fatal AMI and ischemic stroke as separate events. The reported benefits 
of the RYGB on AMI and ischemic stroke have also varied to a great extent 
potentially depending on differences in sample sizes, follow-up times and 
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characteristics of patients.87 In addition, to which extent bariatric surgery 
affects risk of heart failure is not well studied. Due to the strong association 
between BMI and heart failure,51 the substantial weight loss following 




The overall aim of this thesis was to investigate trends in BMI and to 
estimate the impact of body size, body weight and obesity on the risk of early 
CVD and mortality in young women and in obese patients with and without 
surgical treatment for obesity. The aims of the individual studies were: 
I. To investigate trends in social inequalities in BMI in 
young/mid-adulthood women aged 20 to 45 years in 
Sweden. 
 
II.  To investigate the relationship between early adult life body 
size and the risk of atrial fibrillation in women. 
 
III. To investigate the relationship between BMI in young 
Swedish women (aged 18–45 years) and risk of early 
hospitalization for heart failure. 
 
IV. To test the hypothesis that the risk of hospitalization for 
heart failure and overall mortality would decrease among 
patients who have undergone bariatric surgery, compared 
with patients with an obesity diagnosis who have not 
undergone such surgery. 
 
V. To estimate the risk of AMI, ischemic stroke, and 
cardiovascular-related and all-cause mortality after RYGB 
surgery, compared with both non-operated obese patients 
and matched population controls. 
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All studies included in this thesis were based on data from Swedish national 
quality-, health data-, and population registers. These registries are a unique 
source of population-based personal data. The information from these 
registries can be linked through the ten-digit personal identity number (PIN) 
assigned to all Swedish residents at birth or at immigration (see Figure 1). All 
PINs are unique, with the exception of some dates of birth where there is a 
shortage of some PIN combinations, in which case the PIN of deceased 
residents can be reused and given to an immigrant if needed.88 As the 
Swedish healthcare system offers tax-paid primary-, in- and outpatients care 
to all citizens, the quality- and health data registries include more or less 
complete data on all citizens relevant to the register, regardless of household 
income, social status or work status. 
 




THE MEDICAL BIRTH REGISTER (STUDY I–III) 
The Swedish Medical Birth Register was established in 1973 and includes 
99% of all births in Sweden since. It is compulsory for all healthcare 
providers to report information from medical records for prenatal, delivery 
and neonatal care to the registry.89 During the first 10 years, the information 
sent to the register included national Medical Birth Reports, written by 
secretaries at obstetric clinics, with the purpose to communicate information 
between the delivery unit, antenatal centre, and paediatrics health care. From 
1982 and onwards, the content and purpose of the register expanded, and 
came to include information on diseases prior to and during pregnancy, and 
from 1983 and onwards lifestyle factors, such as smoking, pre-pregnancy 
weight, and height. The register was used to collect information on weight, 
height, age, diabetes, hypertension and smoking status for Study I–III. Until 
1990, pre-pregnancy weight was calculated by subtracting gestational weight 
gain from delivery weight. In addition, weight at delivery was reported using 
only two digits, hence, all weights above 99 kg were recorded as 99 kg. 
During 1990 and 1991 no data on pre-pregnancy BMI was collected. Finally, 
from 1993 and onwards weight was measured and height was self-reported 
during the first antenatal visit, which usually occurs between week 8 and 
week 12 of gestation (<12 weeks in 90% of women). Overall, from 1983 and 
onwards the register includes valid information on height and weight in 
approximately 80% and 70% of all women, respectively. 
THE NATIONAL PATIENT REGISTER (STUDY II–V) 
All main and contributory diagnoses from in- and outpatient care are 
registered according to the Swedish version of International Classification of 
Diseases (ICD) in the National Patient Register (Patient register).90 A 
predecessor to the register was first founded in the 1960’s when the National 
Board of Health and Welfare started to collect information on in-patients of 
public hospitals, at the time including only patients treated in psychiatric care 
and some patients in somatic care from 6 of 26 counties in Sweden. From 
1987 and onwards, the register includes complete records on principal and 
contributory discharge diagnoses for all hospitalizations in Sweden, and on 
specialist’s outpatient visits since 2001. The register has been validated 
overall and for specific diseases in several studies. The overall accuracy of 
patient records has been found to be between 85 and 95%, with the highest 
accuracy found among patients treated at internal medicine or cardiology 
departments, with 86% and 95% accuracy, respectively.91 ICD version 8 was 
in use from 1968 to 1986, ICD-9 from 1987 to 1996, and ICD-10 from 1997 
and onwards. All surgical procedures are coded according to the Swedish 
version of the Nordic Medico-Statistical Committees (NOMESCO) 
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Classification of Surgical Procedures Version 1.9. This version was in use 
from 1997 and onwards. 
THE CAUSE OF DEATH REGISTER (STUDY II–V) 
The Cause of Death Register contains data on causes of death from 1961 and 
onwards. There are also historic records from 1952 to 1960. The register 
contains the underlying cause of death coded according to current version of 
the international version of the ICD. The accuracy of the register is high. In 
general, 96% of all individuals in the register has a recorded specified 
underlying cause of death.92 This register was used to collect information on 
dates and causes of deaths for Study II–V. 
THE LONGITUDINAL INTEGRATION DATABASE FOR 
HEALTH INSURANCES AND LABOUR MARKET 
STUDIES (STUDY I–III, V) 
The longitudinal integrated database for health insurance and labour market 
studies (LISA) is a database held by Statistics Sweden.93 It incorporates data 
from several Swedish registers e.g., the register of the total population and 
the Swedish Social Insurance Agency. It contains individual information on 
demographics, education and training, employment/unemployment, and 
income and social insurance. It is also possible to link data for family 
members, and those who share households. Information is available from 
1990 and onwards, and all Swedish citizens who are aged 16 years and older, 
with 80% national coverage. For the purpose of this thesis, we used LISA to 
obtain information on county of residence (Study I), and educational level 
(Study I–III, V). County of residence was collected from the date of the first 
antenatal visit. For Study II, the latest information of the participants’ 
education was used. For Study I, III, and V, educational level was obtained at 
study baseline. Educational level was then categorized into three groups: low 
(<9 years), intermediate (10–12 years), and high (>12 years) level of formal 
education. For Study V, LISA was also used to obtain matched population 
controls from Sweden’s Registry of the Total Population. 
STUDY POPULATIONS AND PROCEDURES 
The cohorts included in the studies in this thesis were derived from The 
Swedish Medical Birth Register (Study I–III), and the NPR (Study IV–V). 
An overview of participants and study designs can be found in Table 2. 
Christina Lundberg 
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Table 2. Overview of participants, data sources, study designs, cohorts in all 
studies. 
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Abbreviations: Patient register= National patient register, LISA= Longitudinal Integration Database for 
health insurances and Labour Market Studies  
PROCEDURE STUDY I–III 
In total, 1,532,449 pregnancies with information on weight and height were 
recorded from 1982 to 2014, of which 1,028,497 was first time pregnancies. 
Inclusion and exclusion criteria for Study I–III can be found in Figure 2. By 
this design, we included 99% of all births in Sweden during these years, and 
>85% of all Swedish women.94 
Measured weight and self-reported height registered during the first antenatal 
visit in the Medical Birth Register was used as a proxy for pre-pregnancy 
weight to calculate BMI. This is generally before any significant pregnancy-
related weight gain, and previous studies describe the weight gain associated 
to pregnancy during this time as negligible (0.5–2.0kg).95, 96 As visual 
inspections of annual body weight deciles showed a larger than expected 
increase in body weight between 1989 and 1992, the weights for these years 
were adjusted by estimating the annual weight increase within deciles from 
1992–2003, with a practically linear result. BMI was divided into eight 
clinically relevant groups: <18.5, 18.5 to <20.0, 20.0 to <22.5, 22.5 to <25.0, 
25.0 to <27.5, 27.5 to <30.0, 30.0 to <35.0 and 35.0 to <60 kg/m2. 
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Abbreviations: BMI= body mass index 
Figure 2. Inclusion and exclusion criteria for Study I–III 
PROCEDURE STUDY IV–V  
Study IV included all patients aged 18 to 74 years who had obtained a first 
recorded principal diagnosis of obesity in the Patient register between 1 
January 2000 and 31 December 2011. Study V included all individuals 20 to 
65 years of age who obtained a first recorded principal diagnosis of obesity in 
the Patient register between 1 January 2001 and 31 December 2013. For each 
patient with obesity, two population controls without any diagnostic code for 
obesity or surgical code for bariatric surgery matched by age, sex and county 
of residence were randomly selected from the Swedish Register of the Total 
Population. Inclusion and exclusion criteria can be found in Figure 3. 
Bariatric surgery codes used for assigning cohorts and censoring are 
presented in Table 3. 
Table 3. Codes from the Swedish version of the NOMESCO 
Classification of Surgical Procedures. 
Procedure NOMESCO codea 
Roux-en-Y gastric bypass JDF10, JDF11 
Vertical banded gastroplasty JDF00, JDF01 
Gastric banding JDF20, JDF21 
Gastric sleeve JDF96, JDF97 
Abbreviations: NOMESCO= Swedish Classification of Operations and Major Procedures 
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a Codes used for defining operation and for censoring bariatric surgery patients before and during study 
periods. Abbreviations: RYGB= Roux-en-Y gastric bypass  
Figure 3. Inclusion and exclusion criteria for Study IV and V. 
In Study IV and V there were two different start dates that had to be take into 
account when calculating person-time at risk. First, the date of obesity 
diagnosis and second the date of bariatric surgery, if they underwent such 
surgery, which potentially could cause an immortal time bias. Immortal time 
bias occurs in cohort studies when participants in the exposed group 
wrongfully is assigned follow-up time that should be accounted to the 
unexposed group.97 There are different approaches to resolve the problem of 
immortal time bias. In this thesis, two approaches were used to investigate 
differences in risk of CVD between bariatric surgery patients and non-
operated obese: multistate disease model (Study IV) and landmark analysis 
(Study V) (see Figure 4). 
MULTISTATE DISEASE MODEL 
In Study IV, we fitted a multistate disease model in order to assess the 
relative risk of heart failure and mortality comparing patients with an obesity 
diagnosis, with and without bariatric surgery. All patients started at the date 
of an obesity diagnosis being recorded (State 1) and transitioned trough the 
model throughout the study period; State 2) bariatric surgery, State 3) Heart 
failure, State 4) Death, State 5) End of study. The relative risks between 
bariatric surgery and non-operated obese patients were then assessed by 
comparing transition probabilities between the states. Hence, person-time in 
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OUTCOMES, EXPOSURES AND COMORBIDITY 
All outcomes and comorbidities were defined by ICD codes in the National 
Patient Register (Study II–V) and the Cause of Death Register (Study IV–V). 
ICD version 8 was in use from 1968 to 1986, ICD version 9 from 1987 to 
1996, and ICD-10 from 1997 and onwards (see Table 4 for diagnostic codes). 
An overview of outcomes and exposures can be found in Table 5. 
 
Table 4. Codes from the Swedish version of the International Classification 
of Diseases 8th, 9th, and 10th revision. 
Diagnosis ICD-8 ICD-9 ICD-10 
Atrial fibrillation 427.92 427D I48 
Cardiomyopathy 425 425 I42, I43 
Congenital heart disease 746, 747 745–747 Q20–Q28, Q87, Q89, 
Q90, Q96 
CHD 410–414 410–414 I20–I25 
Diabetea 250 250 E10–E14 
Heart failure 427.00, 427.10 428 I50 
Hypertensiona 401–405 401–405 I10–I15  
Ischemic stroke 433, 434, 436 434, 436 I63, I64 
Malignancy 140–208  140–208  C00–C97 
AMI 410 410 I21 
Obesity 277 278A, 278B E65, E66 
Sleep apnoea - 327.2, 780.5 G47.3 
Stroke (ischemic and 
haemorrhagic)  
431, 433, 434, 436  431, 433, 434, 436 I61–I64 
Valvular disease 394–396, 398, 424  394–398, 424 I05–I09, I33–I39 
Abbreviations: ICD= international classification of diseases, CHD= coronary heart disease, AMI= acute 
myocardial infarction. The codes were used to define exposure, outcomes and comorbidity. Comorbidity 
was defined as having one of the above stated ICD codes registered in the Nationeal Patient Register 
prior to or at study baseline. a In Study II and III, hypertension and diabetes were defined as diagnosed 
and/ or self-reported 
Body weight, body size and early cardiovascular disease 
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the non-operated group was calculated from obesity diagnosis until first event 
of either bariatric surgery, heart failure, death, or end of study. Person-time 
among the operated group was calculated from date of bariatric surgery until 
a first event of heart failure, death, or end of study. 
Abbreviations: RYGB= Roux-en-Y gastric bypass, AMI= acute myocardial infarction  
Figure 4. Schematic figure over the multistate disease model and the landmark 
analysis. 
LANDMARK ANALYSIS 
In Study V, we used landmark analysis, and assigned a time-point 
(landmark), representing study baseline, two-years after the obesity 
diagnosis. All morbidity and mortality occurring before this landmark were 
considered as comorbidity, and all morbidity and mortality after the two-year 
landmark were considered as events. All participants with an obesity 
diagnosis were then divided into two groups: one group including all patients 
with obesity who underwent RYGB surgery within the two-year landmark, 
and one non-operated obese group, where patients did not undergo any type 
of bariatric surgery within these two years from obesity diagnosis. Through 
this procedure, we included 81% of all individuals who underwent RYGB 
surgery during the study period. 
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In Study I, the exposures were education and county of residence, which 
were used as markers for social inequalities. The outcome studied was trends 
in mean BMI and in the prevalence of BMI categories. In order to make the 
data from 1982 to 2013 comparable, the data was standardised. Because the 
mean age and educational level among first time mothers gradually increased 
over time, age was standardised to the age distribution in 2013 using 5-year 
age groups, and standardised within each educational level. Finally, maternal 
age also differed across counties, hence, all county data were standardised 
within each county, to the age distribution in 2013. For Study II, three 
different anthropometrical measures were assessed as exposure for the risk of 
atrial fibrillation. In addition to the eight BMI categories, we also used BSA 
in the quartiles: 1.12–1.62, 1.63–1.71, 1.72–1.82, and 1.83–3.02, height in cm 
in the quartiles: 150–162, 162–166, 167–170 and >170. For Study III, BMI 
was assessed as exposure for the risk of heart failure. As a large proportion of 
patients diagnosed with heart failure have other primary discharge diagnoses 
e.g., cardiomyopathy or congenital heart disease, a recorded heart failure 
diagnosis in any position was assessed. In addition, a hierarchical 
classification was used to distinguish between mutually exclusive causes of 
heart failure: i) congenital heart disease and valvulopathies, ii) CHD, and/or 
diabetes, and/or hypertension, iii) cardiomyopathy, and (iv) other causes.42 
STUDY IV–V 
In Study IV, any type of bariatric surgery was assessed as exposure for the 
risk of heart failure and mortality among patients with an obesity diagnosis 
from the National Patient Register. In Study V, both diagnosis of obesity and 
RYGB surgery was assessed as exposure for the risk of AMI, ischemic 
stroke, cardiovascular-related and all-cause mortality compared with matched 
population controls without a diagnosis of obesity. 
STATISTICAL ANALYSES 
Descriptive statistics were presented with means and standard deviation (SD) 
or median with interquartile range (IQR) for continuous variables, and 
frequencies with percentages for categorical variables. Differences in 
baseline characteristics (Study II, IV) were determined by two-tailed t-test for 
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Table 5. Overview of outcomes, exposures, follow-up and statistical methods in the separate studies. 
Study I II III IV V
Study baseline First antenatal 
visit 
First antenatal visit First antenatal visit Obesity diagnosis Two-year landmark 
after obesity diagnosis 
Assessed exposure Social 
inequalities 






First diagnosis of atrial 
fibrillation 
First diagnosis of heart failure in 
first or any position 
First diagnosis of heart 







All-cause mortality  







Incidence rat s (Poisson 
regression) 





Cox proportional hazard 
regression models 





Covariates - Model 1: Age 
Model 2: Model 1 + 





educational level, heart 
failure during follow-up 
(time-dependent) 
Model 1: Age, year of 
pregnancy parity  
Model 2: Model 1 + baseline 
disorders: diabetes, stroke, 
hypertension, congenital heart 
disease, cardiomyopathy, atrial 
fibrillation, cancer, valvular 
disease, and CHD 
Model 3: Model 2 + smoking, 
education 
Model 1: Age, sex 
Model 2: Model 1 + 
baseline disorders: 
CHD, hypertension, and 
diabetes 
Model 1: Age, sex, 
educational level 
Abbreviations: BSA= body surface area, BMI= body mass index, RYGB= Roux-en-Y gastric bypass , AMI= acute myocardial infarction, CHD= coronary heart disease
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In Study I, the exposures were education and county of residence, which 
were used as markers for social inequalities. The outcome studied was trends 
in mean BMI and in the prevalence of BMI categories. In order to make the 
data from 1982 to 2013 comparable, the data was standardised. Because the 
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over time, age was standardised to the age distribution in 2013 using 5-year 
age groups, and standardised within each educational level. Finally, maternal 
age also differed across counties, hence, all county data were standardised 
within each county, to the age distribution in 2013. For Study II, three 
different anthropometrical measures were assessed as exposure for the risk of 
atrial fibrillation. In addition to the eight BMI categories, we also used BSA 
in the quartiles: 1.12–1.62, 1.63–1.71, 1.72–1.82, and 1.83–3.02, height in cm 
in the quartiles: 150–162, 162–166, 167–170 and >170. For Study III, BMI 
was assessed as exposure for the risk of heart failure. As a large proportion of 
patients diagnosed with heart failure have other primary discharge diagnoses 
e.g., cardiomyopathy or congenital heart disease, a recorded heart failure 
diagnosis in any position was assessed. In addition, a hierarchical 
classification was used to distinguish between mutually exclusive causes of 
heart failure: i) congenital heart disease and valvulopathies, ii) CHD, and/or 
diabetes, and/or hypertension, iii) cardiomyopathy, and (iv) other causes.42 
STUDY IV–V 
In Study IV, any type of bariatric surgery was assessed as exposure for the 
risk of heart failure and mortality among patients with an obesity diagnosis 
from the National Patient Register. In Study V, both diagnosis of obesity and 
RYGB surgery was assessed as exposure for the risk of AMI, ischemic 
stroke, cardiovascular-related and all-cause mortality compared with matched 
population controls without a diagnosis of obesity. 
STATISTICAL ANALYSES 
Descriptive statistics were presented with means and standard deviation (SD) 
or median with interquartile range (IQR) for continuous variables, and 
frequencies with percentages for categorical variables. Differences in 
baseline characteristics (Study II, IV) were determined by two-tailed t-test for 
continuous variables and chi-square tests for dichotomous variables. 
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Follow-up started at date of antenatal visit (Study II–III), obesity diagnosis 
(Study IV), or at two-year landmark after obesity diagnosis (Study V). In 
Study II–V, all individuals were followed until i) study outcome, ii) death, 
iii) reaching a maximum follow-up of 10 years, or iv) end of follow-up, 31 
December 2014 (Study II–II), 31 December 2012 (Study IV), or 31 
December 2016 (Study V). Incidence rates was calculated as the ratio of 
events and person-years of follow-up time (Study II, IV). In Study III, 
incidence rates with 95% CI were calculated using Poison regression. In 
Study V, age- and sex- adjusted incidence- and mortality rates were 
calculated with approximated 95% CIs. Univariate- and multivariate Cox 
proportional hazard regression models was used to calculate hazard ratios 
(HR) with confidence intervals (CI) in order to calculate relative risk of 
outcomes by exposures in Study II–V. Model adjustments can be found in 
Table 5. Methods based on weighted residuals were used to measure 
proportionality assumptions for the regression models.98 Variables that did 
not fulfil the proportionality assumptions were stratified. All final models 
across studies fulfilled the assumptions of proportional hazard. All statistical 
data management and statistical analyses were performed using SAS version 
9.499 (Study I–V), and R100 versions 4.0.2 (Study I), 3.3.2 (Study II), 3.2.2 
(Study III), and 3.6.2 (Study V). 
STUDY SPECIFIC ANALYSES 
Logistic regression was used to calculate prevalence risk ratios (PRR) with 
95% CI,101 in order to assess differences in proportions of overweight, 
moderate- and severe obesity. PRR was calculated by educational level 
within each period, and stratified by educational level across the six periods 
(Study I).  
Cox regression models was also used to generate spline plots, with BSA, 
BMI and height as restricted cubic splines102 in Study II and BMI in Study 
III, in order to illustrate continuous risk of atrial fibrillation and heart failure. 
The categories BSA: <1.63, and height: <162 was used as references in Study 
I, and BMI 20.0–<22.5 as a reference in Study I–II. In order to assess risk of 
atrial fibrillation by BSA independently from BMI in Study II, the 
multivariable model was stratified by low-normal (18.5–<20.0), normal 
(20.0–<22.5 and 22.5–<25.0), and high BMI (>25.0). In Study III, cox 
regression models was also used to calculated the population-attributable 




In Study V, contrast matrices were used to compare HRs between all four 
groups for all outcomes. As the hazard was not proportional during the ten-
year follow-up, the follow-up time was split in two time periods, and both 
short- (<3years) and long-term (>3–10) risk was assessed. In this study, we 
refrained from including pre-existing comorbidities as covariates, because 
they should not be considered as confounders, as they have a mediating effect 
on the casual pathway between obesity and the outcomes studied. 
ETHICAL CONSIDERATIONS 
All data used in the studies were anonymized by the register holders before 
being handled by any researcher. The investigations are in accordance with 
the principles outlined in the Declaration of Helsinki. The studies were 
approved by the Regional Ethical Review Board in Gothenburg or 
Stockholm, Sweden. The record numbers can be found in Table 6. 
 
Table 6. Ethical approvals 
Study Ethical Review Board Diary number 
Study I–III Gothenburg 103–15 
Study IV Stockholm 2012/210–31/2 
Study V Gothenburg 579–15 
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RESULTS 
An overview of number of participants, age, sex and follow-up time in all 
studies can be found in Table 7. As Study I and V are not yet published, the 
results are presented in condensed form. 
Table 7. Overview of cohorts in all studies. 
Study I II III IV V 
Participants, n 1,022,330 1,522,329 1,374,031 47,859 211,017 
Mean age, 
years 
28.8 28.3 27.9 42.5 42.0 















Abbreviations: n= number, RYGB= Roux-en-Y gastric bypass 
PREVALENCE OF OVERWEIGHT AND OBESITY 
In Study I, the aim was to investigate trends in social inequalities in mean 
BMI and in the prevalence of BMI categories among Swedish women. 
The study period ranged from 1982 to 2013 and incorporated a total of 
1,022,330 women with a mean age of 28.8 years (range 20 to 45 years). 
During the study period, mean BMI increased gradually across all 
educational levels and all Swedish counties, with an overall mean BMI of 
22.7 (SD 3.2) kg/m2 in 1982, to a mean BMI of 24.3 (SD 4.6) kg/m2 in 2013. 
The age-standardised proportions of women with normal BMI (BMI 18.5–
<25 kg/m2) decreased by approximately 15% from the first period to the last. 
Instead, a higher proportion of women were overweight (BMI 25–<30 kg/m2) 
or obese (BMI >30kg/m2), with a prevalence of 22.9% and 10.5%, 
respectively. The proportion of women with moderate and severe obesity 
increased to fairly high levels during the last period. The prevalence of 
overweight and obesity increased substantially across the three educational 
levels over the study period. The age- and education standardised proportions 
of BMI categories by county of residence during the first period 1982–1988 


































































































































































































across counties with a normal BMI decreased by approximately 20%, in 
favour of increasing prevalence of overweight, moderate and severe obesity. 
Throughout the study period, the counties with the three largest Swedish 
cities had the lowest prevalence of overweight and obesity. 
Abbreviations: BMI= body mass index 
Figure 5. Trends in age-standardised prevalence of BMI categories 
RISK OF ATRIAL FIBRILLATION BY BODY SIZE 
AND WEIGHT 
In Study II, we investigated the relationship between body size and weight 
measured early in life, and the risk of atrial fibrillation later in life, among 
Swedish women. 
The study cohort included 1,522,329 women with a mean age of 28.3 years. 
Characteristics at baseline showed that mean BMI increased by increasing 
BSA, and that 68.4% of the women in the highest BSA quartile were 
overweight or obese. Comorbidity was fairly rare regardless of baseline BSA 
and BMI. Over a period of slightly more than 33 years (mean 16.6 years), 
6,993 women (0.5%) were diagnosed with atrial fibrillation. The risk of atrial 
fibrillation increased by all anthropometric measures. The incidence rate 
ranged from 0.18 and 0.19/ 1,000 person-years in the lowest BSA and BMI 
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groups, to 0.45 and 0.63/ 1,000 person-years in the highest (BSA >1.82 and 
BMI >35). 
With the lowest BSA quartiles as a reference, there was a stepwise increase 
in relative risk of atrial fibrillation, with an up to two-fold risk in the highest 
BSA quartile (HR=2.11, CI=1.97–2.26) (see Figure 6). Similar relative risks 
were found for BMI categories, where the risk started to increase at BMI 
22.5–25.0 with a HR of 1.10 (CI=1.03–1.18) up to a HR of 2.77 (CI=2.43–
3.16) for women with BMI >35. The stepwise increased relative risk by BSA 
quartiles persisted after stratifying by BMI categories. 
 
Abbreviations: HR= hazard ratio, CI= confidence intervals, BSA= body surface area, BMI=body mass 
index. The models were adjusted for age, baseline disorders, smoking, pregnancy year, parity, 
educational level, and heart failure during follow-up. 
Figure 6. Risk of atrial fibrillation by BSA quartiles (overall, and in women with 
low normal and high normal weight) and by BMI categories.  
RISK OF HEART FAILURE IN YOUNG WOMEN 
In Study III, we investigated the relationship between early life BMI and the 
long-term risk of heart failure among Swedish women. The study population 
comprised 1,374,031 women with a mean age of 27.9 years. During the 33 
years of follow-up (median 15.3), 2,513 women (0.2%) were hospitalized 
with heart failure recorded as a main or contributory diagnosis. The most 
common comorbidities associated with the heart failure were CHD, diabetes 
or hypertension (957 cases), followed by valvular disease (congenital or 
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The incidence of heart failure in any diagnostic position was lowest for 
women with BMI 20.0–<22.5 with an incidence rate of 8.69 per 100,000 
person-years, and increasing to 34.2/ 100,000 person-years in women with 
BMI >35. The relative risk of heart failure was elevated already at a high-
normal BMI, and increased by each BMI category (see Figure 7). With BMI 
category 20.0–<22.5 as reference, the risk increased stepwise up to almost a 
five times increased risk for women with BMI >35 (HR=4.50, CI=3.41–
5.94). This pattern was similar when assessing the relative risk for mutually 
exclusive related conditions, with the exception of heart failure with valvular 
disease, where no such relation was found. 
 
Abbreviations: CI= confidence intervals, CHD= coronary heart disease. The model was adjusted for age, 
baseline disorders, smoking, pregnancy year, parity, and educational level.  
Figure 7. Risk of heart failure and mutually exclusive related conditions 
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RISK OF HEART FAILURE IN PATIENTS WITH 
OBESITY 
In Study IV, we assessed the risk of heart failure and overall mortality among 
patients with obesity who had undergone bariatric surgery compared with 
that of patients with obesity who did not undergo such surgery. 
During the study period between 1 January 2000 and 31 December 2011, 
47,859 individuals (mean age 42.6 years, 66.8% women) who were 
diagnosed with a principal diagnosis of obesity in the Patient Register were 
eligible for this study. Of those, 22,295 patients (mean age 40.7 years, 75.9% 
women) underwent bariatric surgery. There were 944 (3.7%) cases of heart 
failure among the non-operated obese and 89 (0.4%) cases among the 
operated obese during a mean follow-up time of 3.7 years. In addition, there 
were 938 (3.7%) deaths among the non-operated patients and 251 (1.1%) 
among the operated obese, during a median follow-up time of 3.8 years. 
Incidence of heart failure was substantially higher among the non-operated 
obese compared to the operated obese, with incidence rates of 6.9 and 1.0/ 
1,000 person-years respectively (see Table 8). The relative risk of heart 
failure was substantially lower among the operated obese compared to the 
non-operated obese, with a HR of 0.37 (CI=0.30–0.46). In addition, the 
relative risk of mortality was also lower among the operated obese, but not to 
the same extent as to that of heart failure (HR=0.78, CI=0.68–0.90). 
 
Table 8. Incidence rates and relative risks of heart failure and mortality. 
Outcome Event/ Population Incidence/ mortality 
ratesa (95% CI) 
Multiple-adjusted HR 
(95% CI) 
Heart failure    
   Operated obese 89/22,295 1.0 (0.8–1.3) 0.37 (0.30–0.46) 
   Non-operated obese 944/25,564 6.9 (6.4–7.3) 1 (reference) 
Mortality    
   Operated obese 258/22,295 2.9 (2.6–3.3) 0.78 (0.68–0.90) 
   Non-operated obese 931/25,564 6.7 (6.3–7.1) 1 (reference) 
Abbreviations: CI= confidence intervals, HR= hazard ratio. The model was adjusted for sex, age, and 
baseline disorders. a per 1,000 person-years 
Christina Lundberg 
41 
RISK OF AMI, ISCHEMIC STROKE, 
CARDIOVASCULAR-RELATED AND ALL-CAUSE 
MORTALITY 
In Study V, we estimated the risk of AMI, ischemic stroke, and 
cardiovascular-related and all-cause mortality in obese patients with obesity 
who had undergone RYGB surgery compared with non-operated obese, and 
matched population controls. 
During the study inclusion period, between 1 January 2001 and 31 December 
2013, there were 28,204 patients with obesity who underwent RYGB surgery 
within two years of obesity diagnosis (mean age 40.8 years, 75.5% women). 
In addition, there were 40,827 patients with obesity who did not undergo any 
type of bariatric surgery within two years of obesity diagnosis (mean age 43.1 
years, 68.5% women). In addition, the study population comprised 55,903 
non-obese population controls matched with the RYGB patients and 80,800 
non-obese population controls matched with the non-operated obese.  
The median follow-up times for all outcomes across groups ranged from 4.0–
4.9, where non-operated obese and their population controls had just over 0.5 
years longer follow-up time for most outcomes. RYGB patients had a 
markedly reduced risk of AMI compared with non-operated obese throughout 
the study period. There was no clear difference in relative risk of ischemic 
stroke between the RYGB patients and non-operated obese.  However, the 
RYGB patients had a markedly decreased short-term risk of cardiovascular-
related and all-cause mortality compared with non-operated obese, but not 
thereafter. The RYGB patients had similar risk of AMI, but a persistent 
excess risk of ischemic stroke, cardiovascular-related and all-cause mortality, 
compared with population controls. Non-operated obese had a marked excess 
risk of all outcomes compared with population controls. 
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Table 8. Incidence rates and relative risks of heart failure and mortality. 
Outcome Event/ Population Incidence/ mortality 
ratesa (95% CI) 
Multiple-adjusted HR 
(95% CI) 
Heart failure    
   Operated obese 89/22,295 1.0 (0.8–1.3) 0.37 (0.30–0.46) 
   Non-operated obese 944/25,564 6.9 (6.4–7.3) 1 (reference) 
Mortality    
   Operated obese 258/22,295 2.9 (2.6–3.3) 0.78 (0.68–0.90) 
   Non-operated obese 931/25,564 6.7 (6.3–7.1) 1 (reference) 
Abbreviations: CI= confidence intervals, HR= hazard ratio. The model was adjusted for sex, age, and 
baseline disorders. a per 1,000 person-years 
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RISK OF AMI, ISCHEMIC STROKE, 
CARDIOVASCULAR-RELATED AND ALL-CAUSE 
MORTALITY 
In Study V, we estimated the risk of AMI, ischemic stroke, and 
cardiovascular-related and all-cause mortality in obese patients with obesity 
who had undergone RYGB surgery compared with non-operated obese, and 
matched population controls. 
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non-obese population controls matched with the RYGB patients and 80,800 
non-obese population controls matched with the non-operated obese.  
The median follow-up times for all outcomes across groups ranged from 4.0–
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years longer follow-up time for most outcomes. RYGB patients had a 
markedly reduced risk of AMI compared with non-operated obese throughout 
the study period. There was no clear difference in relative risk of ischemic 
stroke between the RYGB patients and non-operated obese.  However, the 
RYGB patients had a markedly decreased short-term risk of cardiovascular-
related and all-cause mortality compared with non-operated obese, but not 
thereafter. The RYGB patients had similar risk of AMI, but a persistent 
excess risk of ischemic stroke, cardiovascular-related and all-cause mortality, 
compared with population controls. Non-operated obese had a marked excess 
risk of all outcomes compared with population controls. 
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DISCUSSION 
FINDINGS AND IMPLICATIONS 
PREVALENCE OF AND SOCIAL INEQUALITIES IN 
OVERWEIGHT AND OBESITY 
In Study I, we found that mean BMI has increased markedly among young 
first-time mothers during the past decades. This is in line with previous 
studies that also indicates that mean BMI is increasing among young 
individuals in Sweden and worldwide.1, 4, 5 Alongside this marked increase in 
mean BMI, we also found an alarmingly high prevalence rates of moderate 
and severe obesity in 2009–2013, that were more than twice that of the 
prevalence in 1982. In addition, we identified growing social inequalities in 
pre-pregnancy BMI, with a gradient in educational level favouring women 
with higher level of education and living in counties with major cities. These 
results are similar to those found in previous studies linking educational level 
to increased likelihood of overweight and obesity among both younger 
adults,21, 104, 105 and middle-aged populations.106, 107 A recent Swedish 
nationwide study illuminated a similar social gradient in BMI in young men, 
where the differences in prevalence of obesity increased continually from 
1968 to 2005.4 Hence, worryingly, the social inequalities among young 
Swedish men and women are growing and will, if these trends continue, 
cause an increasing divide in serious health problems later in life when CVD 
are more common, where those with lower socioeconomic status will be most 
affected. 
BODY SIZE, OBESITY AND EARLY CARDIO-
VASCULAR DISEASE 
BODY SIZE AND EARLY ATRIAL FIBRILLATION 
In Study II, we identified body size measured early in life as an independent 
risk factor for early onset of atrial fibrillation in young adult women, with a 
stepwise gradient with increasing risk for atrial fibrillation by increasing 
BMI, height, and BSA. This is in line with a previous study where self-
reported body surface in adolescence has been shown to predict risk of atrial 
fibrillation among middle-aged men.67 In addition, previous studies have also 
found a linear association, but between BMI measured later in life, and the 
risk of atrial fibrillation.63, 65, 108 This association was independent of other 
metabolic risk factors.63 Instead, a partial explanatory factor for this 
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relationship could be an enlarged left atrium, which has been associated with 
an increased risk of atrial fibrillation in women with obesity aged 60 years 
and older.109, 110 As the increased risk, observed in our study persisted also in 
women with a larger body size, regardless of BMI, other aspects than obesity 
must also be considered. A hypothesis is that with a larger body size comes 
altered dimensions of the heart, which could play a role in the onset of atrial 
fibrillation. Even though the relationship between body size and atrial 
fibrillation have been well described, more precise investigations considering 
various components of body size with respect to the size of the left atrium, 
should perhaps be investigated further. Both body size and BMI should be 
considered when evaluation patients’ risk of attaining atrial fibrillation. 
Considering the increase in height and weight in most populations world-
wide during recent decades,54, 71 along with the increase in overweight, 
obesity and its sequelae, the prevalence of atrial fibrillation is expected to 
increase, which will have major public health implications. A different 
pathology of future patients with atrial fibrillation might be expected. 
BMI, OBESITY AND EARLY HEART FAILURE 
In Study III, we found a J-shaped relation between BMI in young adulthood 
and risk of heart failure later in life where the lowest risk was found among 
women with BMI 21 kg/m2. The risk started to increase already at high-
normal weight BMI, and women with BMI 35 kg/m2 and over had a fivefold 
increased risk of heart failure. This pattern was evident for mutually 
exclusive related conditions, with the exception of heart failure with valvular 
disease, but particularly for cases of heart failure with CHD, diabetes, or 
hypertension. Similar results have been found in a Swedish population-based 
study of young men (mean age 18 years), where men with BMI 35 kg/m2 and 
over had a tenfold risk of heart failure compared to those with BMI 18–20 
kg/m2, who had the lowest risk.7 The potential mechanisms for the 
relationship between an elevated BMI and the risk of heart failure are 
multiple but not yet entirely clarified. Some potential explanatory 
mechanisms are the impact of obesity on hemodynamic changes, 
neurohormonal activation, and increased oxidative stress.111, 112 These factors 
are in turn associated with cardiac remodelling, left ventricular hypertrophy, 
left atrial enlargement, and ventricular hypertrophy,113, 114 especially in 
individuals with long lasting obesity.115 
In Study IV, we showed that patients with an obesity diagnosis who had 
undergone any type of bariatric surgery had up to a 63% reduced risk of heart 
failure and a slightly reduced risk of mortality, compared with non-operated 
patients with obesity. These results are in line with another study that found a 
54% reduced risk of heart failure after RYGB compared with non-operated 
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obese patients who engaged in a behavioural targeted weight loss 
intervention.116 The differences in risk between these studies were most likely 
due to the differences in achieved weight loss in the control groups during 
follow-up. In our study, we compared bariatric surgery with all patients with 
an obesity diagnosis in the Patient register, regardless of whether they 
underwent any type of treatment for their obesity, with a likely minimal 
weight loss, on average. In the other study,116 the risk of the RYGB patients 
was compared with that of individuals who engaged in a lifestyle 
intervention, after which they obtained a moderate weight loss, while the 
RYGB patients had a marked weight loss post-surgery.116 Thus, these results 
together represent a continuum of risks among patients with obesity, and 
strengthens the causal role between obesity in the development of heart 
failure. This was also confirmed by the stepwise increase in risk of heart 
failure by BMI identified in our study of young women (Study III), and 
previously in young men,7 as well as by previous studies showing that an 
elevated BMI is associated with an increased risk of developing heart 
failure.51, 52 In addition, a recent study found that individuals with the most 
significant weigh loss within one year of the bariatric surgery were also those 
found to have lowest risk of heart failure up to 20 years after baseline.117 
Simultaneously, weight loss after bariatric surgery has been shown to reverse 
the disturbances in the left ventricular function that were caused by 
obesity.118 Hence, the weight loss induced by bariatric surgery is most likely 
the major factor influencing the risk of heart failure among patient who 
undergo bariatric surgery. Furthermore, surgical treatment for obesity is 
associated with lower incidence of known risk factors for heart failure,51 such 
as diabetes, hypertension, and CHD,40 which could be another plausible 
explanation for the lower risk of heart failure post-surgery, as observed in our 
study. 
When assessing the incidence of heart failure, the criteria used to define heart 
failure will have a major impact on the rates. Heart failure is commonly 
diagnosed in primary care, hence, including cases diagnosed in primary care 
will mean a higher incidence of heart failure,119 compared with studies which 
include hospitalizations only.42 In a study including hospitalizations of heart 
failure among Swedish population aged 45–54 years, an incidence of heart of 
about 0.5/ 1,000 person-years was found. In our study of young women, the 
incidence was substantially lower for the women with BMI 20–22.5 with 
rates of 0.09/ 1,000 person-years, but more similar for those with BMI>35 
0.3/ 1,000 person-years. Given that the mean age among these women was 28 
years, and that the risk of heart failure increases substantially with age, lower 
rates were expected among these young women. However, the rates for both 
the operated and non-operated obese patients in those ages in Study IV were 
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2–3 times higher than that of the general population. Hence, even after 
bariatric surgery, there seems to be an excess risk of heart failure compared 
with the general population. 
OBESITY AND EARLY AMI AND ISCHEMIC STROKE  
In Study V, we found that patients with obesity who had undergone RYGB 
surgery had lower 10-year risk of AMI compared with non-operated obese 
patients, and a similar risk to that of controls from the general population. 
Some previous studies of risk of AMI after RYGB surgery shows similar 
results,40, 120, 121 while another did not find any difference between groups up 
to eight years post-surgery.122  
There was no clear association between the RYGB surgery and the risk of 
ischemic stroke. The results showed that RYGB patients and non-operated 
obese patients had similar risks of ischemic stroke during the initial part of 
the follow-up, and a borderline significant reduced risk up to 10 years of 
follow-up. This indicates that the surgery might not be as effective for 
prevention of ischemic stroke, as it seems to be for AMI and heart failure. 
Previous studies have shown somewhat conflicting results. Some studies  
found, in agreement with our study, that RYGB patients maintained an 
excess risk compared with population controls,120 while there was no 
difference compared with non-operated obese patients.121 In contrast, 
compared with non-operated obese patients, previous studies have found a 
34% reduction in fatal and non-fatal ischemic stroke,40 and a marginally 
significant 49% reduction of incidence of  ischemic stroke.121 The differences 
in outcome between studies could be due to differences in definition of stroke 
and follow-up times. It is also likely that RYGB has a varying effect on the 
risk of ischemic stroke. A reduced BMI has been demonstrated to improve 
risk factors for AMI and ischemic stroke, such as serum cholesterol, plasma 
glucose, and blood pressure.38 RYGB surgery has also been associated with 
the improvement of these risk factors,85, 122, 123 and should theoretically reduce 
the risk of AMI and ischemic stroke to the same extent. Unfortunately, we 
lack information on weight status and lifestyle factors that is associated with 
increased risk of AMI and ischemic stroke. RYGB patients who engage in 
healthier behaviours post-surgery have had a more significant and maintained 
weigh loss.124, 125 Speculatively, because the RYGB patients in this study 
represents patients with widely heterogeneous adherence to health-related 
behaviours post-surgery, with widely varying differences in weight loss, 
associations may have been obscured. Furthermore, the RYGB patients in the 
present study were relatively young. As the risk of ischemic stroke increases 
with age, future studies on older populations with longer follow-up might 
find more clear associations. 
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OBESITY AND EXCESS RISK OF MORTALITY 
In Study V, we also found that RYGB surgery seems to delay cardiovascular-
related mortality a few years, with a marked risk reduction during the first 
year’s post-surgery, and a risk that became more parallel to that of non-
operated obese during the latter part of the study. The same magnitude of risk 
reduction was not fond for all-cause mortality, and there was no difference in 
risk between RYGB patients and non-operated obese patients during the 
latter part of the follow-up. An explanation could be that RYGB patients have 
an increased risk of deaths from other causes. Some studies have identified an 
increase in deaths from external causes, such as suicide, accidents, and 
alcoholism among RYGB patients.126, 127 Furthermore, the RYGB patients 
had an excess risk of both cardiovascular-related, and all-cause mortality 
compared with population controls throughout the study period. Larger risk 
reductions were expected, given the negative impact of BMI on 
cardiovascular-related morbidity,38 as well as the associations of RYGB 
surgery with reduction in risk factors and overall risk of CVD and heart 
failure.85, 122, 123 However, some studies have indicated that certain subgroups 
of patients with obesity may benefit more from the surgery than others. 
Factors that have been associated with a large reduction in mortality post-
surgery is male sex128 and higher age.127, 129 Therefore, the heterogeneity of 
the group studied might have attenuated the results. An explanation could 
also be that longer follow-up is needed in order to see greater differences in 
mortality between RYGB patients, non-operated obese and non-obese 
population controls.  
IMPLICATIONS AND LIFETIME PERSPECTIVE  
The alarming increase in mean BMI and in overweight and obesity 
worldwide, particularly in adolescents and young adults, can be described as 
a global obesity epidemic and is a major public and global health concern. As 
described in Study I, the mean BMI in first time mothers has increased by 1.6 
BMI units between 1982 and 2013, with the highest relative increase in the 
prevalence of obesity and severe obesity, along with growing  social 
inequalities. Overweight and obesity in youth have continuously been 
associated with an increased risk of being overweight and obesity also in 
adulthood.29 Additionally, the odds of childhood overweight and obesity are 
substantially increased among children whose mothers had pre-pregnancy 
obesity.130 Because long lasting significant weight loss is hard to achieve,131 
early onset of overweight and obesity are likely to lead to lifelong weight-
management struggles and prevalent overweight and obesity. This tracking of 
obesity throughout the life course has been associated with atherosclerosis,132 
and detrimental to the heart structure where, in particular, long-lasting 
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obesity has been associated with left ventricular systolic and diastolic 
dysfunction, and cardiac remodeling.115 Furthermore, several studies from 
our and other groups have documented an unexpected increase, in an 
otherwise overall downward trend, in onset of early heart failure,42, 133 CHD,43 
and ischemic stroke44, 45 among younger men and women (aged <45). In this 
thesis and in previous studies, we have been able to show that an elevated 
BMI measured early in life is associated with an increased risk of early onset 
of atrial fibrillation (Study II), heart failure,7 (Study III), cardio-
myopathy,134,135 AMI, ischemic stroke, and cardiovascular-related 
mortality.7,8 Also, alarmingly, this increased risk starts already at a low-
normal of BMI of 20.0–22.5 for men and 22.5–25.0 for women. We have 
therefore strong reasons to believe that the increase in BMI, overweight and 
obesity identified among young Swedish men4 and first-time mothers (Study 
I) during the past decades is associated with the contemporary increase in 
early CVD that we now see among young adults aged 55–70 years. Of 
particular concern is that the social inequalities among young Swedish men 
and women are growing and will, if these trends continue, contribute to a 
social divide in serious health problems later in life when CVD are more 
common, where those with lower socioeconomic status will be most affected. 
STRENGTHS AND LIMITATIONS  
A major strength of all studies was the nation-wide coverage, and the ability 
to include all women aged 18–45 years who gave birth in Sweden during the 
study periods (estimated coverage 99%) (Study I–III), and almost all patients 
in Sweden who underwent bariatric surgery during the study time periods 
(Study IV–V). Swedish registry data offers nationwide coverage, high 
accuracy and completeness of data. This, together with the affordable access 
to relatively homogenous health care nationwide, results in high quality 
research data with long-term follow-up, large number of cases, and almost 
complete follow-up of outcomes through the Patient Register and the Cause 
of Death Register.91, 136, 137 
The greatest strengths of these studies are also the source of the greatest 
limitations. Because the population-registers utilized in the studies in this 
thesis were not originally created for research purposes, some of the obtained 
data are limited, and we lack detailed information on many variables of 
interest. The estimation of weight for the study period 1982–1989 in Study I–
III and the self-reported height is a limitation. Although it is unlikely that this 
would have a major impact on the overall pattern described in these large-
scale studies, it should be taken into account when interpreting the results. In 
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STRENGTHS AND LIMITATIONS  
A major strength of all studies was the nation-wide coverage, and the ability 
to include all women aged 18–45 years who gave birth in Sweden during the 
study periods (estimated coverage 99%) (Study I–III), and almost all patients 
in Sweden who underwent bariatric surgery during the study time periods 
(Study IV–V). Swedish registry data offers nationwide coverage, high 
accuracy and completeness of data. This, together with the affordable access 
to relatively homogenous health care nationwide, results in high quality 
research data with long-term follow-up, large number of cases, and almost 
complete follow-up of outcomes through the Patient Register and the Cause 
of Death Register.91, 136, 137 
The greatest strengths of these studies are also the source of the greatest 
limitations. Because the population-registers utilized in the studies in this 
thesis were not originally created for research purposes, some of the obtained 
data are limited, and we lack detailed information on many variables of 
interest. The estimation of weight for the study period 1982–1989 in Study I–
III and the self-reported height is a limitation. Although it is unlikely that this 
would have a major impact on the overall pattern described in these large-
scale studies, it should be taken into account when interpreting the results. In 
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addition, we lack information on other anthropometry such as abdominal 
obesity. However, BMI is considered a good measure for investigating trends 
and prevalence in large populations.2 
We unfortunately lack information on anthropometrical data in Study IV and 
V. However, reports from a Scandinavian obesity surgery registry show that 
that Swedish patients with obesity who underwent bariatric surgery during 
the same time period as that of our studies lost a substantial amount of excess 
weight post-surgery,81 while limited weight reduction was found among non-
operated obese persons.82, 138 Likewise, there was no information on weight 
for the controls from the general population. However, the average BMI 
among Swedish adults is estimated at around BMI 26 kg/m2.1 Far from all 
individuals with obesity have an obesity diagnosis in the Patient register, 
hence, if we would compare the non-operated obese group with population 
controls that had a normal BMI, we might would have found greater risk 
differences between groups. Also, because the diagnosed patients with 
obesity have sought health care for their obesity, they might have worse 
health than those undiagnosed in the general population. 
We lack information on echocardiographic data and severeness of the heart 
failure diagnoses which could be of interest for clinical implications. There 
could be a difference between operated and non-operated obese patients, 
where obese patients undergoing bariatric surgery might suffer from less 
severe heart failure not resulting in hospitalization during the study period. If 
so, we would have overestimated the relative risks between the groups. 
Furthermore, we only had access to data on hospital care. Including data also 
from primary care, especially when assessing morbidity related to overweight 
and obesity, would generate richer information on participants. Even so, 
given that heart failure is a serious condition, it is unlikely that persons within 
this comparably low age span should not have been managed in a hospital 
specialist setting at some point. We only included patients with a principal 
diagnosis of obesity, because those patients are more likely to be those 
actively seeking treatment for their obesity or obesity-related morbidity, in 
contrast to those who receive their obesity diagnosis in conjunction with 
hospitalization for other conditions. If those patients had been included, our 
comparison group would most likely have included individuals that were in 
generally poorer health, unable or unmotivated for treatment, or who might 
not be eligible for surgery.  
Finally, there is a risk of residual confounding in Study II–IV because the 
adjustments of the Cox regression models did not alter the relative risks in a 
significant way. It would be of interest to further look into factors that might 
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account for the remaining risk difference, such as weight change over time 
and important behavioural factors such as smoking, physical activity, dietary 
patterns, and alcohol consumption. 
SELECTION BIAS 
As treatment for obesity is to a great extent placed on the patients’ own 
considerations, knowledge, and responsibility, the effect of the treatment will 
also vary to a great extent. Bariatric surgery is not a standard treatment 
offered to all individuals with obesity. A multidisciplinary bord assesses the 
eligibility of all patients who wants to undergo bariatric surgery, and makes 
an overall assessment of the patients physical and mental health.76 Hence, the 
decision to operate is to a great extent depending on the patients request for 
health care along with the board’s assessment of the mental and physical state 
of the patient. In addition, because there are no randomised controlled trials 
investigating the benefits of bariatric surgery, in all previous studies on 
bariatric surgery the participants were free to choose bariatric surgery or 
conventional obesity treatment. Therefore, all studies on the benefits of 
bariatric surgery compared with non-operated obese patients, introduces a 
selection bias of unknown size, indicating that there will always be 
fundamental differences between the groups. Because not all patients with an 
obesity diagnosis are eligible for surgery, the non-operated obese group 
might have poorer mental and physical health status than the surgery group. 
In addition, there might be other dimensions of patients’ characteristics that 
led to the decision to operate, including eligibility or contraindications to 
surgery and individual preference of the patient.76 Social determinants, such 
as socioeconomic status and possibly other dimensions of patients’ 
characteristics, affects both the prevalence of obesity and treatment seeking 
behavior. Although low socioeconomic status is associated with both obesity 
and risk of CVD,107, 139 a Swedish and a Canadian study (two countries with 
universal health-care insurance systems) have found that individuals with the 
lowest socioeconomic status were less likely to undergo surgery.140, 141 These 
factors all affect both the decision to operate and the patients’ ability to stay 
motivated and to follow recommended post-operation diet plans and physical 
activity to stay healthy, and could therefore play an important role in 
observed risk reduction in the participants who underwent surgery. So far, 
these considerations seem to have received little attention in the context of 
eligibility for bariatric surgery and outcomes after surgery. All these facts 
should be considered when interpreting the results from Study IV and V. 
Body weight, body size and early cardiovascular disease 
48 
addition, we lack information on other anthropometry such as abdominal 
obesity. However, BMI is considered a good measure for investigating trends 
and prevalence in large populations.2 
We unfortunately lack information on anthropometrical data in Study IV and 
V. However, reports from a Scandinavian obesity surgery registry show that 
that Swedish patients with obesity who underwent bariatric surgery during 
the same time period as that of our studies lost a substantial amount of excess 
weight post-surgery,81 while limited weight reduction was found among non-
operated obese persons.82, 138 Likewise, there was no information on weight 
for the controls from the general population. However, the average BMI 
among Swedish adults is estimated at around BMI 26 kg/m2.1 Far from all 
individuals with obesity have an obesity diagnosis in the Patient register, 
hence, if we would compare the non-operated obese group with population 
controls that had a normal BMI, we might would have found greater risk 
differences between groups. Also, because the diagnosed patients with 
obesity have sought health care for their obesity, they might have worse 
health than those undiagnosed in the general population. 
We lack information on echocardiographic data and severeness of the heart 
failure diagnoses which could be of interest for clinical implications. There 
could be a difference between operated and non-operated obese patients, 
where obese patients undergoing bariatric surgery might suffer from less 
severe heart failure not resulting in hospitalization during the study period. If 
so, we would have overestimated the relative risks between the groups. 
Furthermore, we only had access to data on hospital care. Including data also 
from primary care, especially when assessing morbidity related to overweight 
and obesity, would generate richer information on participants. Even so, 
given that heart failure is a serious condition, it is unlikely that persons within 
this comparably low age span should not have been managed in a hospital 
specialist setting at some point. We only included patients with a principal 
diagnosis of obesity, because those patients are more likely to be those 
actively seeking treatment for their obesity or obesity-related morbidity, in 
contrast to those who receive their obesity diagnosis in conjunction with 
hospitalization for other conditions. If those patients had been included, our 
comparison group would most likely have included individuals that were in 
generally poorer health, unable or unmotivated for treatment, or who might 
not be eligible for surgery.  
Finally, there is a risk of residual confounding in Study II–IV because the 
adjustments of the Cox regression models did not alter the relative risks in a 
significant way. It would be of interest to further look into factors that might 
Christina Lundberg 
49 
account for the remaining risk difference, such as weight change over time 
and important behavioural factors such as smoking, physical activity, dietary 
patterns, and alcohol consumption. 
SELECTION BIAS 
As treatment for obesity is to a great extent placed on the patients’ own 
considerations, knowledge, and responsibility, the effect of the treatment will 
also vary to a great extent. Bariatric surgery is not a standard treatment 
offered to all individuals with obesity. A multidisciplinary bord assesses the 
eligibility of all patients who wants to undergo bariatric surgery, and makes 
an overall assessment of the patients physical and mental health.76 Hence, the 
decision to operate is to a great extent depending on the patients request for 
health care along with the board’s assessment of the mental and physical state 
of the patient. In addition, because there are no randomised controlled trials 
investigating the benefits of bariatric surgery, in all previous studies on 
bariatric surgery the participants were free to choose bariatric surgery or 
conventional obesity treatment. Therefore, all studies on the benefits of 
bariatric surgery compared with non-operated obese patients, introduces a 
selection bias of unknown size, indicating that there will always be 
fundamental differences between the groups. Because not all patients with an 
obesity diagnosis are eligible for surgery, the non-operated obese group 
might have poorer mental and physical health status than the surgery group. 
In addition, there might be other dimensions of patients’ characteristics that 
led to the decision to operate, including eligibility or contraindications to 
surgery and individual preference of the patient.76 Social determinants, such 
as socioeconomic status and possibly other dimensions of patients’ 
characteristics, affects both the prevalence of obesity and treatment seeking 
behavior. Although low socioeconomic status is associated with both obesity 
and risk of CVD,107, 139 a Swedish and a Canadian study (two countries with 
universal health-care insurance systems) have found that individuals with the 
lowest socioeconomic status were less likely to undergo surgery.140, 141 These 
factors all affect both the decision to operate and the patients’ ability to stay 
motivated and to follow recommended post-operation diet plans and physical 
activity to stay healthy, and could therefore play an important role in 
observed risk reduction in the participants who underwent surgery. So far, 
these considerations seem to have received little attention in the context of 
eligibility for bariatric surgery and outcomes after surgery. All these facts 
should be considered when interpreting the results from Study IV and V. 
Body weight, body size and early cardiovascular disease 
50 
CONCLUSION 
The findings of the studies of young women in this thesis indicate that:  
- mean BMI is increasing in young Swedish women. The 
proportions of young first-time mothers with moderate and 
severe obesity have increased significantly during the last 
decades while social inequalities are increasing.  
 
- there is a clear association between increasing BSA, BMI 
and height measured early in life and early onset of atrial 
fibrillation. 
 
- there is a clear association between an increased BMI 
measured early in life and early onset of heart failure. 
The findings of the studies of patients with obesity indicates that:  
- bariatric surgery for obesity could prevent early 
hospitalization for heart failure. 
 
- RYGB surgery seems to reduce the risk of AMI and 
postpone cardiovascular-related and all-cause mortality in 
patients with obesity. There was, however, no clear 
association between RYGB surgery and relative risk of 





This thesis contributes with new knowledge by highlighting trends of 
increasing BMI in general, and for moderate and severe obesity in particular, 
among young Swedish first-time mothers. Obesity has a major impact on 
public health and causes great financial costs for societies. Especially morbid 
obesity is the cause of a great economic burden due to increased need for 
health care compared to those who have normal weight.31 Approximately 
50% deaths from CVD and cancer could be prevented by strategically 
focusing on preventive and promotive strategies for modifiable risk factors, 
such as obesity, physical activity and a healthy diet. Furthermore, there is a 
need for structural population-based strategies targeting vulnerable 
subgroups, e.g., those with low socioeconomic status, in order to achieve less 
overweight and obesity across all groups in society,107 and lower rates of 
early-onset cardiovascular morbidity and mortality. 
We also further explored the relationship between obesity and early onset of 
premature morbidity and mortality in CVD. Even though the relationship 
between body size and atrial fibrillation has been well described, more 
precise investigations considering various components of body size with 
respect to the size of the left atrium, should perhaps be investigated further. 
This of course also applies to the relationship between BMI measured early 
in life and later risk of heart failure. It would be of interest to further look into 
and identify factors that might account for risk differences over time, such as 
weight change and important behavioural factors such as smoking, physical 
activity, dietary patterns, and alcohol consumption. 
Given the steep reduction in risk during the first year post-surgery, along 
with the somewhat similar risk during longer follow-up, it is possible that 
RYGB postpones cardiovascular related diseases by a couple of years. What 
impact this shift of risk forward in time has on the overall benefits of surgery 
is yet to be studied. Additional studies should also focus on identifying 
subgroups that gain the greatest benefits from RYGB surgery, as well as 
which patients that might fare better with medical and behavioural targeted 
treatments. Finally, the effect of the selection bias in operated and non-
operated obese patients on cardiovascular outcomes needs to be further 
investigated. More data are needed on characteristics of patients with obesity 
selected for surgical, medical, or behavioural treatment for obesity before a 
firm conclusion on the effectiveness of bariatric surgery for prevention of 
cardiovascular morbidity and mortality can be made.  
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